TY - JOUR
T1 - A structure-based strategy for epitope discovery in burkholderia pseudomallei OppA antigen
AU - Gourlay, Louise J.
AU - Gori, Alessandro
AU - Rinchai, Darawan
AU - Bolognesi, Martino
AU - Lassaux, Patricia
AU - Peri, Claudio
AU - Longhi, Renato
AU - Ferrer-Navarro, Mario
AU - Daura, Xavier
AU - Colombo, Giorgio
AU - Conchillo-Solé, Oscar
AU - Lertmemongkolchai, Ganjana
PY - 2013/1/8
Y1 - 2013/1/8
N2 - We present an approach integrating structural and computational biology with immunological tests to identify epitopes in the OppA antigen from the Gram-negative pathogen Burkholderia pseudomallei, the etiological agent of melioidosis. The crystal structure of OppABp, reported here at 2.1 Å resolution, was the basis for a computational analysis that identified three potential epitopes. In parallel, antigen proteolysis and immunocapturing allowed us to identify three additional peptides. All six potential epitopes were synthesized as free peptides and tested for their immunoreactivity against sera from healthy seronegative, healthy seropositive, and recovered melioidosis patients. Three synthetic peptides allowed the different patient groups to be distinguished, underlining the potential of this approach. Extension of the computational analysis, including energy-based decomposition methods, allowed rationalizing results of the predictive analyses and the immunocapture epitope mapping. Our results illustrate a structure-based epitope discovery process, whose application may expand our perspectives in the diagnostic and vaccine design fields. © 2013 Elsevier Ltd.
AB - We present an approach integrating structural and computational biology with immunological tests to identify epitopes in the OppA antigen from the Gram-negative pathogen Burkholderia pseudomallei, the etiological agent of melioidosis. The crystal structure of OppABp, reported here at 2.1 Å resolution, was the basis for a computational analysis that identified three potential epitopes. In parallel, antigen proteolysis and immunocapturing allowed us to identify three additional peptides. All six potential epitopes were synthesized as free peptides and tested for their immunoreactivity against sera from healthy seronegative, healthy seropositive, and recovered melioidosis patients. Three synthetic peptides allowed the different patient groups to be distinguished, underlining the potential of this approach. Extension of the computational analysis, including energy-based decomposition methods, allowed rationalizing results of the predictive analyses and the immunocapture epitope mapping. Our results illustrate a structure-based epitope discovery process, whose application may expand our perspectives in the diagnostic and vaccine design fields. © 2013 Elsevier Ltd.
UR - https://dialnet.unirioja.es/servlet/articulo?codigo=6362204
U2 - 10.1016/j.str.2012.10.005
DO - 10.1016/j.str.2012.10.005
M3 - Article
SN - 0969-2126
VL - 21
SP - 167
EP - 175
JO - Structure
JF - Structure
ER -